This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on July 6, 2024.

Return to the list of Patented Medicine Litigation page.

---

---

Pegfilgrastim

NEULASTA – Amgen Canada Inc. (NOC Search)

Patents:

• 1297004:
• 1297005:
• 1312569:
• 1339071:
• 1341537: MYLAN, SANDOZ, , APOTEX
• 2178752:

Unknown/Other

• Section 8 – T-744-20
• Other – T-1845-09
• Appeal – A-122-20 (2020 FCA 188) – A-24-19 (2019 FCA 249)
• PM(NOC) – T-34-20
• Infringement – T-7-20

APOTEX

• Section 8 – T-934-16
• Infringement – T-633-16

MYLAN

• PM(NOC) – T-145-17
• Infringement – T-420-19
• Other – T-501-17

SANDOZ

• PM(NOC) – T-1503-18 – T-902-19

---

Return to the Patented Medicine Litigation page.